Nanjing Pharmaceutical Group Company Limited (SHA:600713)
China
· Delayed Price · Currency is CNY 5.35
0.00 (0.00%)
Mar 10, 2026, 2:14 PM CST
SHA:600713 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,003 | 6,494 | 6,342 | 6,709 | 5,114 | 4,635 | Upgrade
|
| Market Cap Growth | 7.40% | 2.41% | -5.47% | 31.18% | 10.34% | -4.92% | Upgrade
|
| Enterprise Value | 18,729 | 17,415 | 18,818 | 16,766 | 14,628 | 11,389 | Upgrade
|
| Last Close Price | 5.35 | 4.80 | 4.51 | 4.65 | 4.35 | 3.86 | Upgrade
|
| PE Ratio | 14.16 | 11.38 | 10.98 | 11.26 | 10.12 | 12.31 | Upgrade
|
| Forward PE | - | 27.42 | 27.42 | 27.42 | 27.42 | 27.42 | Upgrade
|
| PS Ratio | 0.13 | 0.12 | 0.12 | 0.13 | 0.11 | 0.12 | Upgrade
|
| PB Ratio | 0.88 | 0.83 | 0.87 | 1.00 | 0.98 | 0.96 | Upgrade
|
| P/TBV Ratio | 1.05 | 0.99 | 1.03 | 1.18 | 1.20 | 1.19 | Upgrade
|
| P/FCF Ratio | - | 4.08 | 3.63 | - | 13.15 | - | Upgrade
|
| P/OCF Ratio | 132.47 | 3.04 | 3.33 | - | 7.36 | - | Upgrade
|
| EV/Sales Ratio | 0.35 | 0.32 | 0.35 | 0.33 | 0.32 | 0.29 | Upgrade
|
| EV/EBITDA Ratio | 11.42 | 10.41 | 11.38 | 10.87 | 10.10 | 9.79 | Upgrade
|
| EV/EBIT Ratio | 13.36 | 11.33 | 12.55 | 12.07 | 11.25 | 11.09 | Upgrade
|
| EV/FCF Ratio | -98.32 | 10.95 | 10.76 | - | 37.63 | - | Upgrade
|
| Debt / Equity Ratio | 1.60 | 1.31 | 1.26 | 1.83 | 1.89 | 1.80 | Upgrade
|
| Debt / EBITDA Ratio | 7.76 | 5.70 | 5.15 | 7.41 | 6.40 | 7.46 | Upgrade
|
| Debt / FCF Ratio | - | 6.41 | 5.21 | - | 25.38 | - | Upgrade
|
| Net Debt / Equity Ratio | 1.35 | 0.72 | 0.93 | 1.48 | 1.49 | 1.49 | Upgrade
|
| Net Debt / EBITDA Ratio | 7.04 | 3.37 | 4.08 | 6.41 | 5.37 | 6.18 | Upgrade
|
| Net Debt / FCF Ratio | -56.39 | 3.54 | 3.85 | -11.81 | 19.99 | -5.14 | Upgrade
|
| Asset Turnover | 1.62 | 1.82 | 1.79 | 1.75 | 1.83 | 1.76 | Upgrade
|
| Inventory Turnover | 8.01 | 8.33 | 8.68 | 9.12 | 9.83 | 9.58 | Upgrade
|
| Quick Ratio | 1.08 | 1.16 | 1.00 | 0.97 | 0.99 | 0.92 | Upgrade
|
| Current Ratio | 1.45 | 1.63 | 1.40 | 1.31 | 1.34 | 1.23 | Upgrade
|
| Return on Equity (ROE) | 9.15% | 9.88% | 10.22% | 12.00% | 12.15% | 10.06% | Upgrade
|
| Return on Assets (ROA) | 2.63% | 3.25% | 3.12% | 3.02% | 3.30% | 2.83% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.69% | 8.31% | 7.15% | 7.42% | 7.57% | 6.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.10% | 11.30% | 15.20% | 14.80% | 15.60% | 16.60% | Upgrade
|
| Earnings Yield | 7.58% | 8.79% | 9.11% | 8.88% | 9.88% | 8.12% | Upgrade
|
| FCF Yield | -2.72% | 24.50% | 27.57% | -12.48% | 7.60% | -30.19% | Upgrade
|
| Dividend Yield | 3.17% | 3.54% | 3.55% | 3.01% | 2.76% | 2.85% | Upgrade
|
| Payout Ratio | 90.36% | 88.47% | 101.75% | 81.07% | 185.06% | 93.72% | Upgrade
|
| Buyback Yield / Dilution | -7.89% | -0.33% | -3.54% | -20.39% | 0.10% | -0.09% | Upgrade
|
| Total Shareholder Return | -4.73% | 3.21% | 0.00% | -17.39% | 2.86% | 2.76% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.